#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast cancer Transient ischaemic attack Familial haemophagocytic lymphohistiocytosis Infective uveitis Follicle centre lymphoma follicular grade I II – III refractory Lip and/or oral cavity cancer Liver abscess Frontotemporal dementia Lymphoma Pseudomyxoma peritonei Hyperinsulinaemic hypoglycaemia Iron overload Acute leukaemia Proteus syndrome Oesophageal atresia More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Basic Information Chronic granulomatous disease – Basic Information Glomerulonephritis membranous Haemophilia – Treatment Pleural mesothelioma malignant – Diagnostics Lennox-Gastaut syndrome Atypical haemolytic uraemic syndrome – Diagnostics Inclusion body myositis – Basic Information Brain stem glioma – Treatment Cerebral arteriovenous malformation haemorrhagic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Asp1570 AZD4360 Plerixafor AZD0516 Triglycerides, Medium Chain Ethinylestradiol Gebasaxturev Benzylpenicillin Sodium Mometasone Furoate Monohydrate ACETYLCARNITINE HYDROCHLORIDE At-1501 Calcium Chloride Dihydrate Dexmedetomidine LY3841136 SODIUM Terlipressin Acetate Pamapimod Norucholic Acid Perflubutane ASP2957 Nvl-655 More therapies…

    Learn about Your Condition

    Respiratory failure Breast cancer stage IV Small cell carcinoma Niemann-Pick disease Carcinoid tumour pulmonary Liver disorder Brain neoplasm malignant Pharyngeal cancer stage II Supraventricular tachycardia Fragile X syndrome Osteosarcoma Follicular thyroid cancer Colorectal cancer metastatic Hyperthyroidism Gender dysphoria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Laiko General Hospital Of Athens

Laiko General Hospital Of Athens

Messogion Avenue 154, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Fipaxalparant
    Austria France Germany Greece Italy Poland +3

  • Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Atorvastatin
    • Rosuvastatin
    • Inclisiran
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Study on the Effectiveness and Safety of Iptacopan for Adults with Atypical Hemolytic Uremic Syndrome Not Previously Treated with Complement Inhibitors

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atypical haemolytic uraemic syndrome
    Investigated Drugs:
    • Iptacopan
    Austria Czechia Greece Slovakia Slovenia

  • Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pembrolizumab
    Austria Belgium Czechia Denmark Estonia France +11

  • Study of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Lurbinectedin
    • Atezolizumab
    Belgium Germany Greece Hungary Italy Poland +1

  • Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function

    Not recruiting

    3 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Ravulizumab
    Austria Belgium Czechia France Germany Greece +6

  • Study on the Safety and Effectiveness of Polatuzumab Vedotin with Rituximab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Gemcitabine Hydrochloride
    • Oxaliplatin
    France Germany Greece Italy Spain

  • Study on the Effectiveness and Safety of Iptacopan for Patients with Complement 3 Glomerulopathy

    Not recruiting

    3 1
    Investigated Drugs:
    • Iptacopan
    • Iptacopan Hydrochloride
    France Germany Greece Italy The Netherlands Slovakia +1

  • Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

    Not recruiting

    3 1
    Investigated Drugs:
    • Dupilumab
    Belgium Bulgaria Greece Hungary Ireland Romania +1

  • Study of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Atezolizumab
    • Durvalumab
    • Tiragolumab
    Austria Belgium France Germany Greece Hungary +5
Previous Page
1 … 30 31 32 33 34 … 38
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!